Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and trihexyphenidyl

levofloxacin has been researched along with trihexyphenidyl in 1 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(trihexyphenidyl)		Trials
(trihexyphenidyl)		Recent Studies (post-2010) (trihexyphenidyl)
4,3465812,2099508493

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)trihexyphenidyl (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.034
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0055
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.012
Cytochrome P450 2D6Homo sapiens (human)2.4498
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0056
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.015
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.108

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for levofloxacin and trihexyphenidyl

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016